MARKET WRAP: JSE firms on vaccine news, while Shoprite drops on lockdown sales data
Moderna says its preliminary phase 3 trial data shows its Covid-19 vaccine is more than 94% effective
16 November 2020 - 18:26
The JSE tracked firmer global markets on Monday after another Covid-19 vaccine developer reported encouraging results from its trials, while Shoprite lost the most on the day.
American biotechnology group Moderna said on Monday that its preliminary phase 3 trial data showed its Covid-19 vaccine was more than 94% effective — a result CEO Stephane Bancel called a “game changer”...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.